Offline
NIH 'very concerned' about serious side effect in AstraZeneca coronavirus vaccine trial
"AstraZeneca "need to be more forthcoming with a potential complication of a vaccine which will eventually be given to millions of people," said Nath. "We would like to see how we can help, but the lack of information makes it difficult to do so.'"
NIH 'very concerned' about serious side effect in AstraZeneca coronavirus vaccine trial
The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.
www.cnn.com